Molecular imaging market has grown manifold during the course of time, primarily due to increasing demand for detection and monitoring of disease such as cancer and other rare genetic disorders. Molecular imaging is one such technique which has helped to understand the disease complexities in a more efficient manner.
Molecular imaging is a biomedical discipline that provides detailed visualizations and measurement of biologic processes taking place inside the body at molecular, cellular and genetic level. The prime function of molecular imaging is to interrogate biological processes in the cells of the humans or other living organisms to understand the abnormalities and malfunctioning that cause or form the basis of disorders.
Request For Report Sample@ http://www.futuremarketinsights.com/reports/sample/rep-gb-724
Various techniques that have been used in molecular imaging includes Magnetic Resonance Imaging (MRI), Magnetic Resonance Spectroscopy (MRS), X-ray Computed Tomography (CT), ultrasound, optical imaging, single photon emission computed tomography (SPECT) and several others. Amongst all other techniques photon emission tomography (PET) especially SPCET are most commonly used techniques due to their ability to allow interrogation at detailed tissue depths. PET and SPCET scanners generate images of lungs, livers, and hearts and also provide information about the organ’s metabolism and other functions.
Substantial increase in demand for molecular imaging has been reported across the globe. Moreover, developed markets registered highest growth; these markets also represents the largest pie in the global molecular imaging services and devices market. Currently, US tops the global demand for molecular imaging services as well as devices, if countries taken into consideration. In 2013 US accounted for around one half of the global molecular imaging services and devices market.
Molecular imaging helps to detect the illness or disease at the earlier stage and is proved to be very effective to analyze the cardiovascular disease conditions, neurological conditions and cancer stages.
Molecular imagingMarket: Drivers & Restraints
With the Prevalence of cancer and cardiovascular diseases, aging population, advancement in technologies used for molecular imaging such as Nanobiotechnology and robotics, the use of non-ionizing imaging techniques such as MRI and ultrasound systems, growing demand for efficient and accurate imaging system, the adoption hybrid imaging technologies such as PET/CT, continuous improvement and innovation in molecular imaging technologies, the global molecular imaging market is poised to grow with a considerable growth rate during the forecast period 2015-2025.
Molecular imagingMarket: Market Segmentation
The molecular imaging market is broadly classified into seven segments on the basis of techniques
The molecular imaging market is broadly classified into seven segments on the basis of applications
- Cardio Vascular
Molecular imagingMarket: Regional Outlook
Depending on geographic regions, global molecular imaging market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. As of 2015 North America dominated the global molecular imaging market in terms of market revenue. Asia Pacific is anticipated to be the fastest growing market during the forecast period 2015-2025 in which China is poised to emerge as a key destination for molecular imaging device manufacture owing to the growth in competitive business models and infrastructure in this region.
Visit For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-724
Molecular imagingMarket: Market Players
The global molecular imaging market developing with significant growth rate. some of the major players operating in global molecular imaging market are Philips, Siemens, GE Healthcare Affibody, Cyclopharma, Perkin-Elmer, Hamamatsu Photonics, Scintomics, Naviscanand Kereos.